E M El-Omar
Overview
Explore the profile of E M El-Omar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
2828
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Behary J, Raposo A, Amorim N, Zheng H, Gong L, McGovern E, et al.
BMC Microbiol
. 2021 Apr;
21(1):113.
PMID: 33858327
Background: Emerging evidence implicates the gut microbiome in liver inflammation and hepatocellular carcinoma (HCC) development. We aimed to characterize the temporal evolution of gut dysbiosis, in relation to the phenotype...
2.
Malfertheiner P, Megraud F, OMorain C, Gisbert J, Kuipers E, Axon A, et al.
Gut
. 2016 Oct;
66(1):6-30.
PMID: 27707777
Important progress has been made in the management of Helicobacter pylori infection and in this fifth edition of the Maastricht Consensus Report, key aspects related to the clinical role of...
3.
Hunt R, Camilleri M, Crowe S, El-Omar E, Fox J, Kuipers E, et al.
Gut
. 2015 Sep;
64(10):1650-68.
PMID: 26342014
The stomach is traditionally regarded as a hollow muscular sac that initiates the second phase of digestion. Yet this simple view ignores the fact that it is the most sophisticated...
4.
Mukhopadhya I, Hansen R, Meharg C, Thomson J, Russell R, Berry S, et al.
Microbes Infect
. 2014 Dec;
17(4):304-10.
PMID: 25522934
Inflammatory bowel disease (IBD) is characterised by an inappropriate chronic immune response against resident gut microbes. This may be on account of distinct changes in the gut microbiota termed as...
5.
McLean M, Thomson A, Murray G, Fyfe N, Hold G, El-Omar E
Br J Cancer
. 2013 Jun;
108(12):2537-41.
PMID: 23736029
Background: Neutrophil gelatinase-associated lipocalin (NGAL) has a diverse functional repertoire, involved in the innate immune response as well as cell growth and differentiation. Expression has been linked to malignant disease...
6.
Graf N, McLean M, Capellino S, Scholmerich J, Murray G, El-Omar E, et al.
Neurogastroenterol Motil
. 2011 Nov;
24(2):120-8, e83.
PMID: 22093159
Background: Nerve fibers can exert trophic/anti-trophic effects on epithelial cells. Substance P (SP) is a pro-proliferative neuropeptide, whereas sympathetic noradrenaline is anti-proliferative at high concentrations. Methods: Density of noradrenergic and...
7.
Lee Y, Cook M, Bhatia S, Chow W, El-Omar E, Goto H, et al.
Endoscopy
. 2010 Sep;
42(9):699-704.
PMID: 20806154
Background And Study Aim: The establishment of precise and valid diagnostic criteria is important for any disease. We determined the interobserver reliability in the endoscopic diagnosis and grading of Barrett's...
8.
Watanabe O, Ando T, El-Omar E, Shimada M, Ina K, Ishiguro K, et al.
Dig Liver Dis
. 2009 May;
41(10):735-9.
PMID: 19403349
Background And Aims: Although cyclosporin A has been reported to be effective in the treatment of severe ulcerative colitis, factors predicting its therapeutic efficacy remain unclear. Technical progress in endoscopic...
9.
McLean M, Murray G, Fyfe N, Hold G, Mowat N, El-Omar E
Histopathology
. 2008 May;
52(7):806-15.
PMID: 18462368
Aims: To assess cyclooxygenase-2 (COX-2) expression in sporadic colonic adenomas and to explore the association of COX-2 positivity with adenoma characteristics linked to increased risk of malignant transformation. Methods And...
10.
El-Omar E, Ng M, Hold G
Oncogene
. 2008 Jan;
27(2):244-52.
PMID: 18176606
Host genetic factors are emerging as key determinants of disease risk for many cancers. Identifying candidate genes is a major challenge that has to stem from a profound understanding of...